Commitment COM-248
Post-approval commitment for MHRA-2022-0048. Category: Manufacturing. Priority: medium.
Commitment ID
COM-248
Application
Authority
Medicines and Healthcare products Regulatory Agency
Category
Manufacturing
Priority
medium
Status
Overdue
Due Date
2025-01-25
Completed At
—
Owner
Lieselotte van der Berg
Created
2023-03-07
Description
Provide confirmatory bioequivalence study for 200 mg strength
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.